Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
October 2019 Volunteer of the Month - Ketki Patel!
dbrock
GRACE is so honored to work alongside some exceptional volunteers. This month we recognize Ketki Patel!
Image
We couldn't do what we do without you, our volunteers!
From sharing their own philanthropic efforts, helping at the ASCO booth, admin and transcription work, to spreading pamphlets and information about GRACE, to writing informational articles for our community, we have been lucky to have some of the most amazing people volunteer their time and efforts to GRACE.
This month we are pleased to give a huge thank you to Ketki Patel!
Ketki Patel, MHA, is a Program Operations Specialist/Post Award Specialist for the University of Washington Thoracic, Head and Neck Oncology Research Program in Seattle, Washington.
Ketki is an experienced Patient Financial Advocate with a demonstrated history of working with clinical trials/research, medical oncology, and holds knowledge in prior-authorization of inpatient and outpatient chemotherapy and appealing all types of claim denials. She has experience working with the drug manufacturers for drug assistance and copay assistance in the hospital billing setting. She has her Masters in Healthcare Administration and is a Certified Transplant Financial Coordinator.
Ketki has offered GRACE excellent information on navigating the maze of the continuously changing payer landscape; from treatments to medication, genetic testing, and dealing with clinical trials. More information from Ketki will be coming soon - and we are so thrilled to have her as one of our contributors. We are excited to see what comes next.
See Ketki's contributions to GRACE here!
Ketki, Thank you! Your articles on financial help for people dealing with cancer mean so much for our community. For those people dealing with the journey of a cancer diagnosis, the addition of trying to understand the financial burdens placed on them is an added struggle that is something no one should have to deal with. Your gracious gift of information is so helpful. We appreciate and support all of your efforts. We are GRACE because of people like you.
The GRACE Staff
***would you like to volunteer with GRACE? Fill out this volunteer form and a member of our team will get back to you!
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
In this 2nd series of videos, Michael Herman takes us through the story of his diagnosis, his struggles with treatment options, his clinical trial and his learning curve.
Thank you to our Sponsors! #lilly #exelixis
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Online Community
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Recent Comments
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: